We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
The characteristics, symptoms, diagnosis and epidemiology of chikungunya.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
The public has until 3 June to respond to the consultation on the potential reclassification of Nuromol to a general sale list medicine.
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
Reduce development overhead and time to deployment by standardising how teams design, launch and manage APIs in your organisation.
Find out about the long-term effects some people can have after having COVID-19.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
The move will streamline processes within dental and pharmacy settings and improve patient experiences.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.